Related Experiment Video
Updated: Jul 28, 2026
An Optimized Protocol to Analyze Glycolysis and Mitochondrial Respiration in Lymphocytes
Published on: November 21, 2016
Pyruvate metabolism by Anaplasma marginale in cell-free culture
1Department of Molecular Biology, University of Wyoming, Laramie 82071, USA. lmcholla@uwyo.edu
Abstract:
Partially purified Anaplasma marginale initial bodies were cultivated in a cell-free system in the presence of [3-14C]pyruvate for 24 or 48 h. Experiments showed that a significant portion of the pyruvate supplied to the cultures was incorporated into initial body components. Label incorporation was reduced by 72% in the presence of oxytetracycline. Fractionation and chromatography of the organisms revealed radioactive incorporation as alanine. This is the first report of de novo amino acid synthesis by A. marginale demonstrating that the rickettsia is capable of using pyruvate, an erythrocyte glycolytic product, in its metabolism.
Insights
Anaplasma marginale can synthesize its own amino acids using pyruvate, a product from red blood cells. This discovery reveals a new metabolic capability in this important rickettsial pathogen.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Anaplasma marginale is an obligate intracellular bacterium causing significant economic losses in cattle.
- Understanding the metabolic pathways of A. marginale is crucial for developing effective control strategies.
Purpose of the Study:
- To investigate the metabolic fate of pyruvate in Anaplasma marginale initial bodies.
- To determine if A. marginale can perform de novo amino acid synthesis.
Main Methods:
- Cell-free cultivation of partially purified A. marginale initial bodies.
- Use of [3-14C]pyruvate as a tracer to study metabolic incorporation.
- Antibiotic treatment (oxytetracycline) to assess metabolic pathways.
- Fractionation and chromatography to identify incorporated compounds.
Main Results:
- A significant portion of supplied [3-14C]pyruvate was incorporated into A. marginale initial body components.
- Oxytetracycline treatment reduced label incorporation by 72%.
- Radioactive incorporation was identified as alanine, indicating de novo amino acid synthesis.
Conclusions:
- Anaplasma marginale possesses the capability for de novo amino acid synthesis.
- The bacterium utilizes pyruvate, a product of erythrocyte glycolysis, for its metabolism.
- This finding represents the first report of amino acid synthesis by A. marginale.
